ArticleFrontiers in urology2026

Glucagon-like peptide-1 receptor agonist versus other anti-diabetic agents on patients with prostate cancer undergoing androgen-deprivation therapy.

Sheng-Chi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.